Atenolol to treat intestinal ischemia and reperfusion in rats

Transplant Proc. 2012 Oct;44(8):2313-6. doi: 10.1016/j.transproceed.2012.07.058.

Abstract

To study whether treatment with the beta-blocker atenolol (AT) attenuates intestinal dysfunction caused by ischemia (I) and reperfusion (R), rats were treated with AT (1.5 mg · kg(-1), intravenously) or saline solution (SS) prior to I (60 minutes), which was produced by occlusion of the superior mesenteric artery, and/or R (120 minutes). After I or I/R, 2-cm jejunal segments were mounted in an organ bath to study neurogenic contractions stimulated by electrical pulses or KCl using a digital recording system. Thin jejunal slices were stained with hematoxylin and eosin for optical microscopy analysis. Compared to the sham group, jejunal contractions were similar in the I + AT and the I/R + AT groups, but reduced in the I + SS and the I/R + SS groups. The jejunal enteric nerves were damaged in the I + SS and the I/R + SS groups, but not in the I + AT and the I/R + AT. These results suggest that AT may attenuate intestinal dysfunction caused by I and I/R.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-1 Receptor Antagonists / pharmacology*
  • Animals
  • Atenolol / pharmacology*
  • Cytoprotection
  • Disease Models, Animal
  • Electric Stimulation
  • Enteric Nervous System / drug effects
  • Enteric Nervous System / physiopathology
  • Gastrointestinal Agents / pharmacology*
  • Gastrointestinal Motility / drug effects
  • Jejunum / blood supply*
  • Jejunum / drug effects*
  • Jejunum / innervation
  • Jejunum / pathology
  • Jejunum / physiopathology
  • Male
  • Potassium Chloride / pharmacology
  • Rats
  • Rats, Wistar
  • Reperfusion Injury / pathology
  • Reperfusion Injury / physiopathology
  • Reperfusion Injury / prevention & control*

Substances

  • Adrenergic beta-1 Receptor Antagonists
  • Gastrointestinal Agents
  • Atenolol
  • Potassium Chloride